Quick answers
- What is Trokendi XR?
- Trokendi XR is a brand name of Topiramate, a prescription medicine. The FDA NDC Directory lists 4 Trokendi XR products in 4 strengths and forms.
- Who makes Trokendi XR?
- Supernus Pharms holds the FDA application for Trokendi XR (NDA201635, approved August 16, 2013).
- Is there a generic or store brand of Trokendi XR?
- Yes. The FDA NDC Directory lists 76 other products with the same active ingredients, strength and form as a Trokendi XR product, 72 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Trokendi XR?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 4 Trokendi XR strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Trokendi XR been recalled?
- FDA enforcement reports list 4 recalls of Trokendi XR products; the newest started August 31, 2026. A recall usually concerns specific lots, not every product.
What Trokendi XR is
Each Trokendi XR product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Topiramate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| topiramate 100 mg capsule, extended release (oral) | Trokendi XR | 19 products, 15 companies | — |
| topiramate 200 mg capsule, extended release (oral) | Trokendi XR | 19 products, 15 companies | — |
| topiramate 25 mg capsule, extended release (oral) | Trokendi XR | 19 products, 15 companies | — |
| topiramate 50 mg capsule, extended release (oral) | Trokendi XR | 19 products, 15 companies | — |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Topiramate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA201635 | Supernus Pharms | August 16, 2013 | 4 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| topiramate 100 mg capsule, extended release | Brand: Trokendi XR | $34.44 per capsule Generic of the same strength and form: $5.78–$9.10 per capsule |
| topiramate 200 mg capsule, extended release | Brand: Trokendi XR | $47.14 per capsule Generic of the same strength and form: $9.89–$17.41 per capsule |
| topiramate 25 mg capsule, extended release | Brand: Trokendi XR | $13.30 per capsule Generic of the same strength and form: $2.23–$3.66 per capsule |
| topiramate 50 mg capsule, extended release | Brand: Trokendi XR | $17.43 per capsule Generic of the same strength and form: $3.24–$5.67 per capsule |
NADAC list of November 4, 2026; these prices took effect on July 1, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Trokendi XR
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Trokendi XR products.
- Supernus Pharmaceuticals, Inc.4 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
August 31, 2026 · Class III · Ongoing · D-0833-2026
Failed dissolution specifications.
Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 2085 — Supernus Pharmaceuticals, Inc.
-
July 6, 2026 · Class III · Ongoing · D-0758-2026
Failed Dissolution Specifications
Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 U — Supernus Pharmaceuticals, Inc.
-
March 15, 2021 · Class II · Terminated · D-0570-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Trokendi XR (topiramate) extended-release capsules 100 mg 30 Capsules Rx only, Manufactured by: Catalent Pharma Solutions Winchester, KY 40391 USA Manufactured for: Supernus Pharmaceuticals, Inc. Rockville, MD 20850 USA, — Cardinal Health Inc.
-
July 12, 2016 · Class II · Terminated · D-0112-2017
Superpotent Drug: Failure of assay specifications in the capsule.
Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 2 — Supernus Pharmaceuticals, Inc.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.